New therapies for relapsed or refractory aggressive B-cell lymphoma increase survival: Analysis from the RELINF registry of the GELTAMO group.
Mariana Bastos-OreiroPau AbrisquetaAntonio GutierrezAna Jiménez UbietoMaria PozaPaula Fernanez-CaldasMaría José LLacerSonia Gonzalez de VillambrosiaRaúl CórdobaAlberto LópezElena CeballosBelen NavarroAna MuntañolaEva DonatoEva Diez-BaezaLourdes EscodaHugo LuzardoMaría José PeñarrubiaDaniel García BelmonteEmilia PardalClaudia LozadaAlejandro Martín García-SanchoPublished in: HemaSphere (2024)